Aspen Aerogels (ASPN) Sees Downgrade and Price Target Cut by Barclays | ASPN Stock News

Author's Avatar
May 29, 2025
Article's Main Image

On May 29, 2025, Aspen Aerogels (ASPN, Financial) experienced a significant shift in its stock outlook following an update from Barclays. The analyst firm, represented by David Anderson, revised its rating for the company from "Overweight" to "Equal-Weight". This change indicates a more neutral stance on the stock's potential performance compared to its previous optimistic outlook.

In conjunction with the downgrade in rating, Barclays also adjusted the price target for Aspen Aerogels (ASPN, Financial). The new price target is set at USD 7.00, a notable reduction from the previous target of USD 13.00. This adjustment represents a 46.15% decrease in the expected stock price, highlighting a significant reevaluation of the company's future financial prospects.

The actions and revised projections from Barclays underscore a recalibrated assessment of Aspen Aerogels (ASPN, Financial), as investors and stakeholders take into account the current market conditions and company performance indicators.

Wall Street Analysts Forecast

1928075666880884736.png

Based on the one-year price targets offered by 7 analysts, the average target price for Aspen Aerogels Inc (ASPN, Financial) is $12.43 with a high estimate of $32.00 and a low estimate of $7.00. The average target implies an upside of 93.59% from the current price of $6.42. More detailed estimate data can be found on the Aspen Aerogels Inc (ASPN) Forecast page.

Based on the consensus recommendation from 9 brokerage firms, Aspen Aerogels Inc's (ASPN, Financial) average brokerage recommendation is currently 2.3, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Based on GuruFocus estimates, the estimated GF Value for Aspen Aerogels Inc (ASPN, Financial) in one year is $10.44, suggesting a upside of 62.62% from the current price of $6.42. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Aspen Aerogels Inc (ASPN) Summary page.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.